CO2017009182A2 - Cepas bacterianas productoras de histamina para tratamiento del cáncer - Google Patents

Cepas bacterianas productoras de histamina para tratamiento del cáncer

Info

Publication number
CO2017009182A2
CO2017009182A2 CONC2017/0009182A CO2017009182A CO2017009182A2 CO 2017009182 A2 CO2017009182 A2 CO 2017009182A2 CO 2017009182 A CO2017009182 A CO 2017009182A CO 2017009182 A2 CO2017009182 A2 CO 2017009182A2
Authority
CO
Colombia
Prior art keywords
histamine
bacterial strains
producing bacterial
cancer treatment
cancer
Prior art date
Application number
CONC2017/0009182A
Other languages
English (en)
Inventor
James Versalovic
Bo Möllstam
Chunxu Gao
Bhanu Ganesh
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CO2017009182A2 publication Critical patent/CO2017009182A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01107—Diacylglycerol kinase (2.7.1.107)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

RESUMEN DE LA DIVULGACIÓN. La invención del presente documento divulga cepas bacterianas productoras de histamina para ser usadas en la profilaxis, inhibición, tratamiento o reducción del riesgo de recaída de cáncer, incluyendo el cáncer colorrectal. La presente invención también divulga el uso de cepas bacterianas productoras de histamina para la manufactura de un medicamento para el tratamiento del cáncer, incluyendo el cáncer colorrectal en hombres.
CONC2017/0009182A 2015-03-26 2017-09-12 Cepas bacterianas productoras de histamina para tratamiento del cáncer CO2017009182A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562138491P 2015-03-26 2015-03-26
PCT/SE2016/050253 WO2016153422A1 (en) 2015-03-26 2016-03-24 Histamine-producing bacterial strains and their use in cancer

Publications (1)

Publication Number Publication Date
CO2017009182A2 true CO2017009182A2 (es) 2017-11-30

Family

ID=55755642

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0009182A CO2017009182A2 (es) 2015-03-26 2017-09-12 Cepas bacterianas productoras de histamina para tratamiento del cáncer

Country Status (19)

Country Link
US (2) US20180104287A1 (es)
EP (1) EP3274052B1 (es)
JP (2) JP2018510631A (es)
KR (1) KR102707791B1 (es)
CN (1) CN107709541A (es)
AU (1) AU2016236124B2 (es)
BR (1) BR112017019660A2 (es)
CL (1) CL2017002275A1 (es)
CO (1) CO2017009182A2 (es)
ES (1) ES3062285T3 (es)
GE (2) GEP20207089B (es)
HK (1) HK1251013A1 (es)
IL (1) IL254139B (es)
MX (1) MX2017012359A (es)
PH (1) PH12017501741A1 (es)
RU (1) RU2747390C2 (es)
SG (1) SG11201705479UA (es)
WO (1) WO2016153422A1 (es)
ZA (1) ZA201705121B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
CA3023867A1 (en) * 2016-05-09 2017-11-16 Biogaia Ab Selection of bacterial strains useful in allergy treatment
CN108707557B (zh) * 2018-03-23 2021-04-16 景岳生物科技股份有限公司 预防、改善或减缓胰腺癌之益生菌组合物及其应用
CN112236513B (zh) 2018-07-24 2023-09-19 生命大地女神有限公司 选择和使用褪黑素支持细菌以减少婴儿绞痛
CN111004757B (zh) * 2019-12-31 2021-11-02 深圳市沁帆科技有限公司 一种罗伊氏乳杆菌、微生物菌剂及食物制品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846807B1 (en) * 2003-07-25 2005-01-25 Board Of Regents, The University Of Texas System Colorectal neoplasia prophylaxis
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine

Also Published As

Publication number Publication date
JP2021052795A (ja) 2021-04-08
RU2017135070A3 (es) 2019-08-06
CL2017002275A1 (es) 2018-03-09
BR112017019660A2 (en) 2018-05-15
ZA201705121B (en) 2019-10-30
GEP20207089B (en) 2020-04-10
AU2016236124A1 (en) 2017-09-21
KR20170128245A (ko) 2017-11-22
EP3274052C0 (en) 2026-01-14
CN107709541A (zh) 2018-02-16
RU2747390C2 (ru) 2021-05-04
HK1251013A1 (zh) 2019-01-18
US20230241136A1 (en) 2023-08-03
JP7140820B2 (ja) 2022-09-21
IL254139B (en) 2022-06-01
KR102707791B1 (ko) 2024-09-19
JP2018510631A (ja) 2018-04-19
SG11201705479UA (en) 2017-10-30
AU2016236124B2 (en) 2021-04-15
IL254139A0 (en) 2017-10-31
PH12017501741A1 (en) 2018-03-19
WO2016153422A1 (en) 2016-09-29
EP3274052B1 (en) 2026-01-14
GEAP201914591A (en) 2019-11-11
EP3274052A1 (en) 2018-01-31
ES3062285T3 (en) 2026-04-09
US20180104287A1 (en) 2018-04-19
CA2980544A1 (en) 2016-09-29
MX2017012359A (es) 2018-07-06
RU2017135070A (ru) 2019-04-08

Similar Documents

Publication Publication Date Title
CL2019002304A1 (es) Compuestos para el tratamiento del cáncer.
CL2018003316A1 (es) Compuestos para la inhibición de k-ras y para el tratamiento del cáncer. (divisional solicitud 201702786)
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
ECSP17029203A (es) Inhibidor de cinasa aurora a
EA201891340A1 (ru) Лечение рака с использованием 2-дезокси-2-фтор-l-фукозы в комбинации с ингибитором контрольных точек
MX2017013802A (es) Métodos para tratar el cáncer.
TN2019000211A1 (en) Antitumoral compounds
CO2020015923A2 (es) Antagonista de gremlin-1 para la prevención y tratamiento del cáncer
CO2017009182A2 (es) Cepas bacterianas productoras de histamina para tratamiento del cáncer
AU2015267099A8 (en) Use of eribulin in the treatment of cancer
BR112017009265A2 (pt) apilimode para uso no tratamento do câncer colorretal
MX2019009304A (es) Tratamiento para el cancer.
JO3541B1 (ar) علاجات طبية قائمة على اناموريلين
EA201890868A1 (ru) Бактерии с ослабленной вирулентностью для лечения злокачественных солидных опухолей
CY1120573T1 (el) Παραγωγα πυριδαζινης για χρηση στην προληψη ή θεραπεια αταξικης διαταραχης
MX2017016346A (es) Metodos de tratamiento con taselisib.
MX382092B (es) Compuestos heterocíclicos para el tratamiento de enfermedades.
PH12017501063A1 (en) Compounds for the treatment of cancer
AR104200A1 (es) Carboximetilcisteina para tratamiento tópico de estrías
AR115575A1 (es) Antagonista gremlin-1 para la prevención y tratamiento del cáncer
EA202091730A1 (ru) Комбинированная терапия для лечения или профилактики рака
EA202091636A1 (ru) Комбинированная терапия для лечения или профилактики рака
EA202091635A1 (ru) Комбинированная терапия для лечения или профилактики рака
GB2546703A (en) Compounds